Kiadis announces U.S. FDA approval of the Abigail Wexner Research Institute at Nationwide Children’s Hospital’s IND for a COVID-19 clinical trial with off-the-shelf K-NK cells using Kiadis’ proprietary platforms https://t.co/fkYEZpLdqI
Kiadis announces U.S. FDA approval of the Abigail Wexner Research Institute at Nationwide Children's Hospital's IND for a COVID-19 clinical trial with off-the-shelf K-NK cells using Kiadis proprietary platforms https://t.co/fkYEZpLdqI
Advancing cell-based immunotherapy for patients with life threatening diseases. Guidelines: https://t.co/CcDhTFsijP
Advancing cell-based immunotherapy for Patients with life threatening diseases. Guidelines: https://t.co/CcDhTFsijP